We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

Chris Viehbacher has departed from his role as chief executive of Sanofi after the company's board voted to remove him. Having taken over at the Paris-based company six years ago, German-Canadian ...

Drugmaker Sanofi has suddenly fired its CEO, Chris Viehbacher. The board met early this morning. The stock fell nearly 14% in premarket trading on NYSE, its down on the Paris exchange too.

Sanofi's CEO, Chris Viehbacher, has told a French newspaper that the drugmaker will stick to smaller acquisitions, with a plan to spend 1 to 2 billion euros each year on acquisitions.

The new CEO, Christopher Viehbacher, is working to improve the company’s pipeline, most recently with their acquisition of ...

Biogen CEO Chris Viehbacher has praised PM Modi''s vision of making India central to the technological progress of the 21st century. "I think the PM has a vision that the 21st century is driven by ...

The new CEO, Christopher Viehbacher, is working to improve the company’s pipeline, most recently with their acquisition of Human Immunology Biosciences Inc. in May. Chris has a strong track ...

Biogen's Chris Viehbacher, HP's Enrique Lores, and IBM's Arvind Krishna, among others. Nvidia CEO Jensen Huang called Prime Minister Modi an "incredible student". "Every time I meet him ...

Biopharmaceutical company Biogen has picked a new CEO, former Sanofi CEO Christopher Viehbacher, amid fallout from its failed Alzheimer's drug launch. Department of Health and Human Services ...

(Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that Eisai has initiated the rolling submission of a Biologics License ...